Imaging of Inflammation and Treatment: Basic and Translational Potential
炎症成像和治疗:基础和转化潜力
基本信息
- 批准号:8088215
- 负责人:
- 金额:$ 30.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-10 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAnimalsAntirheumatic AgentsArthritisBiocompatibleBloodBlood VolumeCaliforniaChemical EngineeringClinicalContrast MediaDevelopmentDevicesDiagnostic ImagingDiseaseDisease modelDrug Delivery SystemsDrug EvaluationDrug KineticsElementsEngineeringEnvironmentEtanerceptEvaluationFDA approvedFunctional ImagingGoldHumanHypoxiaImageImageryImaging technologyIncidenceInflammationInflammatoryJointsLabelLaboratory AnimalsLaboratory StudyLasersLifeLightMagnetic Resonance ImagingMalignant NeoplasmsMedicalMedical ImagingMedicineMetabolicMethodsMichiganModelingMolecularMolecular TargetMonitorNuclearOpticsPainPatternPeripheralPharmaceutical PreparationsPharmacologic SubstancePhysiologicalPlayProteinsRadiology SpecialtyRattusResearchResearch PersonnelResolutionResourcesRheumatoid ArthritisRheumatologyRoleRouteSchoolsSignal TransductionSpeedSynovitisSystemTechniquesTechnologyTestingTherapeuticTherapeutic AgentsTimeTissuesTransducersTreatment EfficacyTumor Necrosis Factor-alphaUltrasonic TransducerUltrasonographyUnited States National Institutes of HealthUniversitiesWorkabsorptionbaseclinical practicecytokinedesigndisease diagnosishemodynamicsimaging modalityimprovedin vivoinnovationinstrumentinstrumentationinterestintravenous administrationmedical schoolsmolecular imagingnanocolloidnanorodnoveloptical imagingoverexpressionpolyvinylidene fluorideresponsesoft tissuesubcutaneoussuccesstime usetomographytooltreatment effectuptake
项目摘要
DESCRIPTION (provided by applicant): The therapy and diagnosis of diseases at the cellular and molecular levels will be improved greatly with the development of medical imaging technologies that can not only monitor the delivery of analytical probes or therapeutic agents but also enable comprehensive and objective evaluation of treatment effects. As an emerging noninvasive, nonionizing light-based technology presenting both high contrast and high spatial resolution, photoacoustic tomography (PAT) may be developed into a novel and promising molecular imaging modality which will generate innovations and play a critical role in medicine. We propose to investigate an even more advanced spectroscopic PAT (SPAT) technique using inflammatory arthritic disease models, patterned after widely known, very costly, painful, and disabling disorders, for demonstration of the method. SPAT, when aided by a newly developed gold nanocolloid contrast agent, may create innovations with an extensive impact in various biomedical applications, not only in more efficient evaluation of drug effects in living laboratory animals but also in optimized therapeutic decisions in clinical practice. The SPAT system for human/animal inflammatory arthritis will be developed on a stand-alone commercial ultrasound unit which, in an exclusive research mode allows acquisition of light-induced ultrasound signals with 64 independent channels simultaneously. This capability will for the first time enable near real-time 2D PAT and fast speed 3D PAT. Gold nanorods with the optical absorption peak tuned to the NIR region will be conjugated with Etanercept (Enbrel(r)), an FDA approved drug for rheumatoid arthritis. Due to the strong optical absorption by gold nanorods, the SPAT system working with a designed PVDF array transducer holds promise in imaging the drug uptake in regional arthritic tissues. Besides drug delivery monitoring, the unique ability of SPAT in evaluating treatment efficacy will also be examined through the comparison with nuclear imaging and MRI conducted on the same animals quasi-simultaneously. By imaging the morphological and physiological hallmarks of synovitis including hypervascularization and hypoxia, SPAT may realize comprehensive evaluation of the early responses of arthritic tissues to the pharmaceutical treatment. This research is anticipated to develop instrumentation and techniques that may significantly contribute to diagnostic imaging and therapeutic monitoring of various disorders including inflammatory diseases and cancer.
说明(申请人提供):随着医学成像技术的发展,不仅可以监测分析探针或治疗剂的递送,而且可以全面客观地评价治疗效果,将大大改善细胞和分子水平上的疾病治疗和诊断。作为一种新兴的非侵入性、非电离光成像技术,光声层析成像(photoacoustic tomography,PAT)具有高对比度和高空间分辨率的特点,有望成为一种新型的、有前途的分子成像技术,在医学领域发挥重要作用。我们建议研究一种更先进的光谱PAT(SPAT)技术,使用炎症性关节炎疾病模型,模式后广为人知的,非常昂贵的,痛苦的,和禁用的疾病,演示的方法。SPAT在新开发的金纳米胶体造影剂的帮助下,可能会在各种生物医学应用中产生广泛影响的创新,不仅在活体实验动物中更有效地评估药物作用,而且在临床实践中优化治疗决策。用于人类/动物炎症性关节炎的SPAT系统将在一个独立的商业超声单元上开发,该单元在独家研究模式下允许同时采集64个独立通道的光诱导超声信号。该功能将首次实现近实时2D PAT和快速3D PAT。具有调谐到近红外区域的光学吸收峰的金纳米棒将与FDA批准的治疗类风湿性关节炎的药物依那西普(Enbrel(r))结合。由于金纳米棒的强光吸收,SPAT系统与设计的PVDF阵列换能器一起工作,有望在局部关节炎组织中成像药物摄取。除了药物递送监测外,还将通过与在相同动物上准同时进行的核成像和MRI进行比较来检查SPAT在评估治疗效果方面的独特能力。SPAT通过对滑膜炎的形态和生理特征(包括血管增生和缺氧)进行成像,可以全面评估关节炎组织对药物治疗的早期反应。这项研究预计将开发仪器和技术,可能显着有助于诊断成像和治疗监测各种疾病,包括炎症性疾病和癌症。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of bladder microvasculature with high-resolution photoacoustic imaging.
- DOI:10.1364/ol.36.004815
- 发表时间:2011-12-15
- 期刊:
- 影响因子:3.6
- 作者:Xie Z;Roberts W;Carson P;Liu X;Tao C;Wang X
- 通讯作者:Wang X
A fiber-optic system for dual-modality photoacoustic microscopy and confocal fluorescence microscopy using miniature components.
- DOI:10.1016/j.pacs.2013.07.001
- 发表时间:2013-05-01
- 期刊:
- 影响因子:7.9
- 作者:Chen, Sung-Liang;Xie, Zhixing;Guo, L Jay;Wang, Xueding
- 通讯作者:Wang, Xueding
Sonophoric nanoprobe aided pH measurement in vivo using photoacoustic spectroscopy.
- DOI:10.1039/c3an00093a
- 发表时间:2013-06-07
- 期刊:
- 影响因子:0
- 作者:Ray A;Yoon HK;Koo Lee YE;Kopelman R;Wang X
- 通讯作者:Wang X
Photoacoustic imaging with a commercial ultrasound system and a custom probe.
- DOI:10.1016/j.ultrasmedbio.2010.12.005
- 发表时间:2011-03
- 期刊:
- 影响因子:2.9
- 作者:Wang, Xueding;Fowlkes, J. Brian;Cannata, Jonathan M.;Hu, Changhong;Carson, Paul L.
- 通讯作者:Carson, Paul L.
Quantitatively Understanding Cellular Uptake of Gold Nanoparticles via Radioactivity Analysis.
通过放射性分析定量了解金纳米粒子的细胞摄取。
- DOI:10.1166/jnn.2015.9486
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Shao,Xia;Schnau,Paul;Qian,Wei;Wang,Xueding
- 通讯作者:Wang,Xueding
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XUEDING WANG其他文献
XUEDING WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XUEDING WANG', 18)}}的其他基金
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
8513127 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
8328935 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
8699013 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
9389824 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
8025132 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Physiology of Inflammatory Arthritis in High Resolution
高分辨率炎症性关节炎的生理学
- 批准号:
10205976 - 财政年份:2011
- 资助金额:
$ 30.92万 - 项目类别:
Imaging of Inflammation and Treatment: Basic and Translational Potential
炎症成像和治疗:基础和转化潜力
- 批准号:
7464978 - 财政年份:2008
- 资助金额:
$ 30.92万 - 项目类别:
Imaging of Inflammation and Treatment: Basic and Translational Potential
炎症成像和治疗:基础和转化潜力
- 批准号:
7869350 - 财政年份:2008
- 资助金额:
$ 30.92万 - 项目类别:
Imaging of Inflammation and Treatment: Basic and Translational Potential
炎症成像和治疗:基础和转化潜力
- 批准号:
7608639 - 财政年份:2008
- 资助金额:
$ 30.92万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Continuing Grant